Multiple Sclerosis Journal is a peer-reviewed international journal that focuses on all aspects of multiple sclerosis, neuromyelitis optica and other related autoimmune diseases of the central nervous system. The journal for your research in the following areas: Biologic basis; Epidemology and genetics; Clinical and Neuroimaging; Therapeutics and rehabilitation.
The Lancet Neurology was launched in May, 2002, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to neurologists worldwide.
JINS is the official journal of the International Neuropsychological Society, an organization of over 4,700 international members from a variety of disciplines. Our editorial board is comprised of internationally known experts with a broad range of interests. JINS publishes empirically-based articles covering all areas of neuropsychology and the interface of neuropsychology with other areas, such as cognitive neuroscience. Theoretically driven work that has clinical implications is of particular interest.
The Journal of Pain publishes original articles related to all aspects of pain, including clinical and basic research, patient care, education, and health policy. Articles selected for publication in the Journal are most commonly reports of original clinical research or reports of original basic research. In addition, invited critical reviews, including meta analyses of drugs for pain management, invited commentaries on reviews, and exceptional case studies are published in the Journal.
Neurosurgery, the official journal of the Congress of Neurological Surgeons, publishes top research on clinical and experimental neurosurgery covering the very latest developments in science, technology, and medicine. The journal attracts contributions from the most respected authorities in the field. It includes a wealth of information applicable to researchers and practicing neurosurgeons. This journal is indispensable as the most comprehensive source in neurosurgery.
JNNP's ambition is to publish the most ground-breaking and cutting-edge research from around the world. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson's disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS.
The Journal of NeuroInterventional Surgery (JNIS) is a leading peer review journal for scientific research and literature pertaining to the field of neurointerventional surgery. The journal launch addressed growing professional interest in neurointerventional techniques for the treatment of a range of neurological and vascular problems including stroke, aneurysms, brain tumors, and spinal disorders.
Journal of Clinical Sleep Medicine is the official, peer-reviewed journal of the American Academy of Sleep Medicine. This monthly, online publication features original scientific investigations, reviews, case reports and commentaries applicable to the clinical diagnosis and treatment of sleep disorders. Since 2005, sleep specialists have turned to Journal of Clinical Sleep Medicine for the information they need to remain proficient in the diagnosis and treatment of the broad spectrum of sleep disorders.
JAMA Neurology is an international peer-reviewed journal for physicians caring for people with neurologic disorders and those interested in the structure and function of the normal and diseased nervous system. The Archives of Neurology & Psychiatry began publication in 1919 and, in 1959, became 2 separate journals: Archives of Neurology and Archives of General Psychiatry. In 2013, their names changed to JAMA Neurology and JAMA Psychiatry, respectively.
The central focus of the journal is on research that advances understanding of existing and new neuropsychopharmacological agents including their mode of action and clinical application or provides insights into the biological basis of psychiatric disorders and thereby advances their pharmacological treatment.